Skip to main content
Top
Published in: Journal of Neurology 8/2019

01-08-2019 | Original Communication

Amyotrophy, cerebellar impairment and psychiatric disease are the main symptoms in a cohort of 14 Czech patients with the late-onset form of Tay–Sachs disease

Authors: Helena Jahnová, Helena Poupětová, Jitka Jirečková, Hana Vlášková, Eva Košťálová, Radim Mazanec, Alena Zumrová, Petr Mečíř, Zuzana Mušová, Martin Magner

Published in: Journal of Neurology | Issue 8/2019

Login to get access

Abstract

Background

Tay–Sachs disease (TSD) is an inherited neurodegenerative disorder caused by a lysosomal β-hexosaminidase A deficiency due to mutations in the HEXA gene. The late-onset form of disease (LOTS) is considered rare, and only a limited number of cases have been reported. The clinical course of LOTS differs substantially from classic infantile TSD.

Methods

Comprehensive data from 14 Czech patients with LOTS were collated, including results of enzyme assays and genetic analyses.

Results

14 patients (9 females, 5 males) with LOTS were diagnosed between 2002 and 2018 in the Czech Republic (a calculated birth prevalence of 1 per 325,175 live births). The median age of first symptoms was 21 years (range 10–33 years), and the median diagnostic delay was 10.5 years (range 0–29 years). The main clinical symptoms at the time of manifestation were stammering or slurred speech, proximal weakness of the lower extremities due to anterior horn cell neuronopathy, signs of neo- and paleocerebellar dysfunction and/or psychiatric disorders. Cerebellar atrophy detected through brain MRI was a common finding. Residual enzyme activity was 1.8–4.1% of controls. All patients carried the typical LOTS-associated c.805G>A (p.Gly269Ser) mutation on at least one allele, while a novel point mutation, c.754C>T (p.Arg252Cys) was found in two siblings.

Conclusion

LOTS seems to be an underdiagnosed cause of progressive distal motor neuron disease, with variably expressed cerebellar impairment and psychiatric symptomatology in our group of adolescent and adult patients. The enzyme assay of β-hexosaminidase A in serum/plasma is a rapid and reliable tool to verify clinical suspicions.
Literature
1.
go back to reference Gravel RA, Kaback MM, Proia RL, et al (2014) The GM2 Gangliosidoses. In: The online metabolic and molecular bases of inherited diseases Gravel RA, Kaback MM, Proia RL, et al (2014) The GM2 Gangliosidoses. In: The online metabolic and molecular bases of inherited diseases
2.
go back to reference Kaback MM, Desnick RJ (2011) Hexosaminidase A deficiency. In: Pagon R, Adam M (eds) GenReviews, pp 1993–2018 Kaback MM, Desnick RJ (2011) Hexosaminidase A deficiency. In: Pagon R, Adam M (eds) GenReviews, pp 1993–2018
3.
go back to reference Chen H, Chan AY, Stone DU, Mandal NA (2014) Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders. Surv. Ophthalmol. 59:64–76CrossRefPubMed Chen H, Chan AY, Stone DU, Mandal NA (2014) Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders. Surv. Ophthalmol. 59:64–76CrossRefPubMed
7.
go back to reference Neudorfer O, Pastores GM, Zeng BJ et al (2005) Late-onset Tay–Sachs disease: phenotypic characterization and genotypic correlation in 21 affected patients. Genet Med 7:119–123CrossRefPubMed Neudorfer O, Pastores GM, Zeng BJ et al (2005) Late-onset Tay–Sachs disease: phenotypic characterization and genotypic correlation in 21 affected patients. Genet Med 7:119–123CrossRefPubMed
8.
go back to reference Steiner KM, Brenck J, Goericke S, Timmann D (2016) Cerebellar atrophy and muscle weakness: late-onset Tay–Sachs disease outside Jewish populations. BMJ Case Rep 31:5 Steiner KM, Brenck J, Goericke S, Timmann D (2016) Cerebellar atrophy and muscle weakness: late-onset Tay–Sachs disease outside Jewish populations. BMJ Case Rep 31:5
10.
go back to reference Prihodova I, Kalincik T, Poupetova H et al (2013) Late-onset Tay–Sachs disease can mimic spinal muscular atrophy type III—two case reports. Ces a Slov Neurol a Neurochir 76:221–224 Prihodova I, Kalincik T, Poupetova H et al (2013) Late-onset Tay–Sachs disease can mimic spinal muscular atrophy type III—two case reports. Ces a Slov Neurol a Neurochir 76:221–224
12.
go back to reference Wenger D, Williams C (1991) Screening for lysosomal disorders. In: Hommes FA (ed) Techniques in diagnostic human biochemical genetics. Willey-Liss, New York, pp 587–617 Wenger D, Williams C (1991) Screening for lysosomal disorders. In: Hommes FA (ed) Techniques in diagnostic human biochemical genetics. Willey-Liss, New York, pp 587–617
19.
go back to reference Neudorfer O, Kolodny EH (2004) Late-onset Tay–Sachs disease. Isr Med Assoc J 6:107–111PubMed Neudorfer O, Kolodny EH (2004) Late-onset Tay–Sachs disease. Isr Med Assoc J 6:107–111PubMed
Metadata
Title
Amyotrophy, cerebellar impairment and psychiatric disease are the main symptoms in a cohort of 14 Czech patients with the late-onset form of Tay–Sachs disease
Authors
Helena Jahnová
Helena Poupětová
Jitka Jirečková
Hana Vlášková
Eva Košťálová
Radim Mazanec
Alena Zumrová
Petr Mečíř
Zuzana Mušová
Martin Magner
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 8/2019
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09364-3

Other articles of this Issue 8/2019

Journal of Neurology 8/2019 Go to the issue

Letter to the Editors

Insufficient image quality